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In the largest disease-mapping project 
ever conducted, health workers trained by 
the Global Trachoma Mapping Project 
have already examined the eyelids of more 
than 1 million people in nearly 1,000 
districts since December 2012. The data 
collected are being used to create the first 
truly complete global map of trachoma and 
trichiasis, due in March 2015. 
Data on the prevalence of trachoma 
and trichiasis at country and district level 
are vital in order to plan public health 
interventions and to mobilise resources. 
The public health interventions are based 
on the SAFE strategy for trachoma elimi-
nation, a strategy endorsed by the World 
Health Organization (WHO). SAFE is short 
for Surgery, Antibiotics, Facial cleanliness 
and Environmental improvement. It involves 
offering individuals with trichiasis – the 
blinding consequence of trachoma – a 
surgical procedure to stop their lashes being 
in contact with the eyeball. In populations 
with active trachoma, SAFE also involves 
offering antibiotics, education (about facial 
cleanliness and other good hygiene 
practices) and environmental improvement 
to reduce the carriage and transmission 
of the bacterium that causes trachoma. 
In order to plan surgical services 
adequately, it is useful to know the preva-
lence of trichiasis: that is, where there are 
people with trichiasis and approximately 
how many are affected. To plan antibiotic 
distribution, facial cleanliness, education 
and improvements in water and sanitation 
for trachoma control purposes, it is 
essential to know the prevalence of active 
trachoma. This information must be 
collected at health district level, because 
health districts (populations of 100,000–
250,000) are the units in which SAFE is 
usually put into practice. 
 
Why is mapping needed? 
Trachoma is thought to be endemic in 
2,400 districts worldwide. By July 2012, 
district-level surveys had established 
prevalence estimates in less than half of 
these (1,115 districts). The rest, (1,285 
districts) were merely suspected to be 
endemic, without sufficient information to 
either start interventions in those places 
or to confidently add them to the list of 
districts for which full-scale SAFE imple-
mentation did not seem necessary.
In July 2012, therefore, Sightsavers, 
the International Trachoma Initiative (ITI) 
and the London School of Hygiene & 
Tropical Medicine, acting on behalf of the 
International Coalition for Trachoma 
Control, secured the £10.6 million Global 
Trachoma Mapping Project (GTMP) grant 
from the United Kingdom’s Department 
for International Development. Following 
an intensive planning and piloting phase, 
mapping commenced in the Oromia Region 
of Ethiopia on 17 December 2012, soon 
followed by projects in other regions of 
Ethiopia and in other countries. 
How is the mapping conducted? 
Each suspected endemic area is subdi-
vided into ‘evaluation units’ comprising 
populations of 100,000–250,000 
(these are generally equivalent to health 
districts). For the purposes of the 
mapping project, however, larger popula-
tions can be mapped as a single evaluation 
unit if trachoma is suspected to be highly 
and widely endemic.
In each project location, ministry of 
health staff are trained and certifi ed by 
GTMP training teams. A population-
based prevalence survey of more than 
20 clusters (based on WHO guidelines) is 
then undertaken by those teams for each 
evaluation unit. Data are collected on 
water and sanitation at the household 
level, and on age, gender and the 
presence or absence of signs of 
trachoma at an individual level. 
All data are collected electronically, 
using Android smartphones running the 
LINKS app, which has been developed and 
is maintained by the Task Force for Global 
Health, Atlanta, GA, USA. Data are 
geo-referenced using global positioning 
system coordinates; they are then trans-
mitted to a high security server for cleaning 
and approval by the relevant ministry of 
health (using a site-specifi c password-
protected web interface). Analysis of 
approved data is automatic, using 
pre-agreed algorithms, and prevalence 
categories are then displayed (with 
ministry of health agreement) on the 
web-based Global Atlas of Trachoma.1 Use 
of all of these elements of cutting-edge 
technology means that results can be 
ready for use for the population’s benefi t 
within days of fi eldwork being completed. 
An additional advantage is that the results 
are considerably less prone to errors in 
data handling than the paper-based 
systems used in previous surveys. 
The benefi ts of the GTMP approach 
have been recognised by ITI’s Trachoma 
Expert Committee and by other agencies. 
For example, two non-governmental 
organisations (FHI360 and RTI International), 
both funded by the United States Agency 
for International Development, are 
working with the GTMP to conduct 
trachoma surveys in countries whose 
trachoma programmes they support.
Progress thus far
By the beginning of March 2014, the 
GTMP was working with 18 implementing 
organisations in more than 30 countries, 
and some of the 21 million 'bits' of GTMP 
data had already been put to use to 
approve the deployment of Pfizer-donated 
azithromycin for mass antibiotic distri-
bution. The project will continue until 
March 2015, paving the way for the launch 
of SAFE interventions – wherever required – 
to reach the 2020 target of eliminating 
trachoma as a public health problem. 
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A health worker 
examines the eyelids 
of a child in Yemen.
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